Journal of Prevention and Treatment for Stomatological Diseases (JPTSD), is a double-blind peer-reviewed open-access academic journal in stomatology. JPTSD provides free and quick publication for accepted manuscripts. No fees are charged, and remuneration will be paid. Authors should read the following instructions before submission.

This journal is held and published by Southern Medical University Stomatological Hospital and Guangdong Oral Health Center, established in 1993. It is a monthly journal of stomatology that is publicly published both domestically and overseas; ISSN 2096-1456 (Print); ISSN 2097-0234 (Online); CN 44-1724/R; CODEN KJFOA4. It is a core journal of Chinese science and technology, an excellent science and technology journal of Guangdong, and an excellent Chinese university science and technology journal (2022). JPTSD is included in the U.S. “Ulrich Journal Guide”, Scopus, Embase, Directory of Open Access Journals (DOAJ), WHO Western Pacific Regional Medical Index (WPRIM), Index of Copurnicus, Japan Science and Technology Agency (JST), Health InterNetwork Access to Research Initiative (HINARI), China Science and Technology Papers Statistics Source Database, China Biomedical Literature Database, China Academic Journal (Network Edition), Wanfang Database, Weipu Network “Chinese Technology Journal Database” and other important domestic and foreign databases.

JPTSD mainly reports the latest progress, achievements, experiences, technologies and methodologies in the field of stomatology. It focuses on preventive and clinical treatments characterized by a combination of theory, practice, popularization and improvement. The journal emphasizes innovation and discovery and aims to meet authors’ needs, serve readers, benefit society and promote the development of oral medicine. It has the following columns: Expert Forum, Basic Research, Clinical Trial, Prevention and Treatment Practice, and Review. Authors are welcome to submit papers via the https://www.kqjbfz.com.

1. Requirements and precautions for the manuscript

(1) Statement: A cover letter is required for every submitted article to prove the authenticity of the manuscript. There must be no confidentiality infringement or multiple submissions. The authorship must be uncontested. A conflict of interest statement and each author's contribution should be indicated on the first page of the article in both Chinese and English. For clinical trials involving human subjects, the author should indicate whether the procedures followed comply with the ethical standards established by the committee responsible for human trials (institutional, regional or national), provide the committee's approval number, and indicate whether informed consent was obtained from the subject or his/her relatives. For clinical trials, the author must provide a globally unique "trial registration number" and the name of the registrar obtained from the WHO International Clinical Trial Registration Platform Level 1 registry in both Chinese and English at the end of the Chinese and English abstract. For animal experiments, the laboratory animal qualification certificate number and the approval number of the Ethics Committee must be provided and recorded in the paper. Identification information from the study, including patients’ names, initials, and portraits or hospital names, should not be disclosed except when there is written evidence that it is important for scientific purposes and the informed consent of the patient (parent or guardian) has been obtained. Patients should read the published manuscript before signing the informed consent certificate. Identification information should be omitted if it is not necessary.

If an article is about a project funded by national or provincial funds or research projects, the official names of the fund projects should be listed in both Chinese and English on the first page of the article, and the project number should be indicated. The funds should be listed individually, and scanned copies of supporting documents for the funding projects should be attached.

(2) Overall requirements: Articles should be creative, scientific, readable and practical. They must contain authentic information, explicit arguments, a clear hierarchy, and reliable data. Statistical processing should be performed when necessary. The main column article format is shown in the paper template on the official website. The sentences should be concise, and the writing should be clear. Expert forum, basic research, clinical study articles and reviews should not exceed 8,000 Chinese characters, including the English abstract, figures, tables and references; and case reports should not exceed 6,000 words.

(3) Title: The title should concisely and accurately reflect the theme of the article and should not exceed 20 Chinese characters. Abbreviations should be avoided.

(4) Authorship: Authorship provides credit for a researcher's contributions to a study and carries responsibility and accountability. JPTSD implements the ICMJE recommend that authorship be based on the following 4 criteria:

　1) Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND

　2) Drafting the work or reviewing it critically for important intellectual content; AND

　3) Final approval of the version to be published; AND

　4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

All those designated as authors should meet all four criteria for authorship, and all who meet the four criteria should be identified as authors. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

When a large, multicenter group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the acknowledgments section.

Please refer to the ICMJE authorship guidelines for more information on authorship. The authors should be listed in order of the size of their contribution, and the author unit should be indicated. If the authors belong to different organizations, a superscripted 1, 2, or 3 should be used after their names to indicate the corresponding organizations. The postal code and name of the city of the organization as well as the professional title, degree, and email address of the corresponding author and the first author should be provided. The information about the authors and organizations appears on the title page to facilitate the double-blind review of the manuscript.

(5) Abstract: Execute GB/T 6447-1986 “Rules for abstracts and abstracting”. The paper should be accompanied by a four-paragraph structured Chinese abstract of approximately 400 Chinese characters, which should be divided into objectives, methods, results (including main data and statistical results) and conclusions. The review and review categories should be accompanied by a Chinese abstract of approximately 400 words, which should reflect the literature review results, the author's views and future research directions. The contents of the Chinese and English abstracts should be consistent.

(6) Key words: For each article, 8 to 10 words or phrases should be selected that reflect the topic content of the manuscript and conform to the medical thesaurus.

(7) English items: The title, author names (including corresponding author), organization names, addresses, postal codes, abstract, figure legends, and table titles in English should correspond with those in Chinese.

(8) Medical terminology: Medical terminology should be based on the “Medical Terms” published by the National Natural Science Terminology Verification Committee and the “English-Chinese Medical Vocabulary” complied by the People’s Health Publishing House. Drug names should be based on the latest version of “Pharmacopoeia of the People’s Republic of China.” The use of trade names is not allowed.

(9) Figures and tables: CY/T 171-2019 “Specication of academic publishing—Illustration”and CY/T 170-2019 “Specication of academic publishing—Table” should be followed. All figures (tables) should have a complete short and exact figure title (table title), and a brief descriptive caption should be provided for each figure. The text in the figure (table), the figure title (table title) and the figure notes (table notes) must be in both Chinese and English. The journal uses a three-line table format. Typical lesions shown in photos in the text should be marked with arrows 4 mm long and 1 mm wide. Staining methods and magnification or scale should be indicated for pathological photos. Color should be used for bar charts. Repetition of text, figures and tables should be avoided, and charts must be self-explanatory. All images should be submitted in uncompressed TIFF format with a resolution of no less than 800 dpi for line drawings, 300 dpi for half-tone drawings, and 600 dpi for color and combination drawings. Each piece of image should be individually packaged and uploaded as an attachment. The width of a single-column composite diagram should not exceed 7 cm, the width of a general-column composite diagram should not exceed 16.2 cm, and the height of a composite diagram should not exceed 20 cm.

(10) Units of measurement: GB 3100-1993 “SI units and recommendations for the use of their multiples and of certain other units” .and GB/T 3101-1993 “General principles concerning quantities，units and symbols” and GB/T3102.1(Quantities and units of space and time)~3102.13-1993

(Quantities and units of solid state physics) should be followed. The relevant provisions of “Quantity and Unit” should be followed and expressed by the appropriate unit symbol. In charts and tables, the ratio of the quantity to the unit symbol should be represented.

(11) Digital: GB/T 15835-2011 " General rules for writing numerals in public texts" should be followed.

(12) Statistics: statistical symbols should always be in italics, and the specific names of statistical analysis methods, the specific values of statistics (such as: t value), and specific P values should be indicated.

(13) Abbreviations: The full Chinese word should be indicated when a term not publicly known appears for the first time, followed by the full English name and abbreviation in parentheses.

(14) References: References should be selected from official publications published in recent years that the author personally read and listed according to GB/T 7714-2015 “Information and documentation—Rules for bibliographic references and citations to information resources.” A sequential coding system should be adopted, and references should be marked with Arabic numerals and square brackets according to the order in which they are cited in the text. The posted references should be consistent. At the end of the article, the reference items should be listed in sequence with square brackets. When a Chinese reference is cited, the article should be recorded first in Chinese and then in English. The English translation of the author's name should be expressed in Chinese pinyin, with the first letter of the surname capitalized and the first letter of the name capitalized based on the initials of the syllable, and used in the English description of the Chinese publication name. The English abbreviation of the publication name should not use the Chinese pinyin name when there is no standard English abbreviation of the full English publication title. For documents with DOI codes, the DOI should be listed at the end of the article. References must be verified against the original text, abstracts should not be quoted as references, and the author of a reference must have the same name as that cited in the text.

Examples of the reference format: Journal: [serial number] Author's name (use all if there are no more than 3 authors; when there are more than 3, use only the first 3 followed by "et al." or any other corresponding text. A foreign author's last name is first, followed by the initials. Title. Publication name (abbreviate foreign periodical titles according to Index Medicus or use no abbreviations), year, volume (issue): page span. Acquisition and access paths (required for electronic resources). Unique identifiers for digital objects (required for electronic resources).

[Journal] [1] Pamudurti NR, Bartok O, Jens M, et al. Translation of circRNAs[J]. Mol Cell, 2017, 66(1):9-21. doi: 10.1016/j.mol-cel.2017.02.021.

[2] 陈树伟, 杨安奎, 张诠, 等. 单中心24 年1 915 例口腔鳞癌的临床病理特征和生存分析[J]. 口腔疾病防治, 2020, 28(8): 487-493. doi: 10.12016/j.issn.2096-1456.2020.08.002.

Chen SW, Yang Ak, Zhang Q, et al. Analysis of clinicopathological characteristics and survival of 1 915 oral cavity squamous cell carcinoma patients: 24-year experience from a single institution[J]. J Prev Treat Stomatol Dis, 2020, 28 (8): 487-493. doi: 10.12016/j.issn.2096-1456.2020.08.002.

[3] 石炳毅, 刘志佳. 肾移植: 从质量控制到质量提升计划[J/OL]. 中华移植杂志(电子版), 2018, 12(3): 97-101 [2018-12-10]. http://rs.yiigle.com/CN119290201803/1074260.htm. doi: 10.3877. cma. j. issn. 1674-3903. 2018.03.001.

Shi BY, Liu ZJ. Kidney transplantation: from quality control to quality improvement plan[J/OL]. Chin J Transplant (Elec- tronic Edition), 2018, 12(3): 97-101 [2018-12-10]. http://rs.yiigle.com/CN119290201803/1074260.htm. doi: 10.3877. cma. j. issn. 1674-3903. 2018.03.001.
[Book] [1] 冯海兰, 徐军. 口腔修复学[M]. 2 版. 北京: 北京大学医学出版社, 2013.

Feng HL, Xu J. Prosthodontics[M]. 2nd ed. Beijing: Peking University Medical Press, 2013.

[2] Deverell W, Igler D. A companion to California history[M/OL]. New York: John Wiley & Sons, 2013: 21-22(2013-11-15) [2019-08-29]. https://onlinelibrary.wiley.com/doi/book/10.1002/9781444305036. doi:10.1002/9781444305036.

(15) Foreign symbols: Foreign symbols should be in the correct format, including upper- or lowercase and normal, italicized, superscripted, or subscripted text.

2. Submission processing

(1) Papers should be submitted via the official https://www.kqjbfz.com, "Online submission" and self-checked according to the format and requirements of the journal. The authors will be notified of the first editorial decision within 1 week and can check the status of the submission through the online system.

(2) The editorial office will contact the corresponding author, first author, or contact person specified by the first author (or second author) regarding matters related to the manuscript.

(3) The original manuscript should be kept by the authors, as the submitted manuscript will not be returned.

(4) Authors are responsible for their own manuscript. According to “Copyright Law,” the journal has the right to make amendments to the manuscript within the stated provisions. In the case of any modifications involving the original meaning, the journal will ask for suggestions from the authors. If it is not possible for the authors to submit a revised manuscript within 3 months, the journal will consider the paper a new submission.

(5) To adapt to the domestic construction of informatization and to expand the channels of communication between the journal and the authors, the journal has been included in numerous databases. The copyright fee for the article and the royalties will be onetime payments. Statistically analyzed data regarding article citations will be provided to the authors freely. If the authors refuse to allow the article to be included in the databases, the authors should provide a statement when submitting the manuscript, and the journal will make appropriate arrangements.

(6) The authors will be provided with 2 issues of the journal after publication of the accepted paper. The authors should contact the editorial office if additional issues are needed.

(7) The authors should inform the editorial office of any awards received by the paper or study.

(8) Beware of fake websites. Should the authors have any questions, they should feel free to contact the editorial office.